Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

Autor: Daniela Moye-Holz, Jitse P van Dijk, Sijmen A. Reijneveld, Hans V. Hogerzeil

Publikováno v: Globalization and Health, Vol 13, Iss 1, Pp 1-10 (2017)

Abstract Background The World Health Organization recommends establishing and implementing a national pharmaceutical policy (NPP) to guarantee effective and equitable access to medicines. Mexico has implemented several policy approaches to regulate t

Externí odkaz: https://doaj.org/article/fcbaed4cfff64ccb98db094ee3b4d15a

Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study

Autor: Thomas Piggott, Lorenzo Moja, Elie A. Akl, John N. Lavis, Graham Cooke, Tamara Kredo, Hans V. Hogerzeil, Benedikt Huttner, Pablo Alonso-Coello, Holger Schünemann

Publikováno v: Journal of Clinical Epidemiology. 154:146-155

The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and explicit decision criteria. Essential medicines should be a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e09270533176ac3e38569d2ecf26bd
https://doi.org/10.1016/j.jclinepi.2022.12.007

Legislating for universal access to medicines

Autor: Hans V Hogerzeil, S. Katrina Perehudoff, Nikita V. Alexandrov

Publikováno v: Health Policy and Planning, 34(Supp. 3), 48-57. Oxford University Press
Health Policy and Planning
HEALTH POLICY AND PLANNING

Universal health coverage (UHC) aims to ensure that all people have access to health services including essential medicines without risking financial hardship. Yet, in many low- and middle-income countries (LMICs) inadequate UHC fails to ensure unive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2de9d52d0fd7930a5c6e7900ab8a440
https://doi.org/10.1093/heapol/czy101

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico

Autor: J M C van Dijk, R. Soria, Anahí Dreser, D. Moye Holz, Margaret Ewen, Hans V Hogerzeil, S. Bautista, Sijmen A. Reijneveld

Publikováno v: BMC Health Services Research
BMC Health Services Research, 20(1):424. BioMed Central Ltd.
BMC Health Services Research, Vol 20, Iss 1, Pp 1-11 (2020)

Background: More alternatives are becoming available for the diagnosis and treatment of cancer in low- and middle-income countries. Yet, because of increasing demands, many governments are now facing the dilemma of making essential cancer medicines a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17793c36331e4c28f10505bdafaddc2
https://doi.org/10.21203/rs.2.18891/v2

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016

Autor: Brigit Toebes, Hans V Hogerzeil, Ellen 't Hoen, Jacquelyn D Veraldi

Publikováno v: Bulletin of the World Health Organization
Bulletin of the World Health Organization, 96(3), 185-193. WORLD HEALTH ORGANIZATION

Millions of people, particularly in low- and middle-income countries, lack access to effective pharmaceuticals, often because they are unaffordable. The 2001 Ministerial Conference of the World Trade Organization (WTO) adopted the Doha Declaration on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5841e3723056113b46482ecdc7c04138
http://europepmc.org/articles/PMC5840629